Biocartis Group NV , an innovative molecular diagnostics company, today announces the publication in the renowned clinical oncology journal The Lancet Oncology of an important study[1] by Prof. Dr. Bart Neyns from the University Hospital in Brussels (Belgium). In this ...
Read More »
San Francisco, CA | Translational Medicine Job Summary This position will be responsible for biomarker discovery and diagnostic development for rucaparib and other Clovis programs. This positon will work effectively with Translational Medicine, Biostatistics, Clinical Development, Regulatory, Clinical Operation, and ...
Read More »
Exosome Diagnostics is expanding our laboratories in the IZB in Martinsried. We are looking for a Senior Project Manager, experienced in medical devices/diagnostic development who can guide core teams through a regulated product development cycle, including CE marking and FDA ...
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced the completion of an additional $17.6 million round of financing in an extension of its Series B financing, bringing the total Series B financing raise to ...
Read More »
from Genetic Engineering & Biotechnology News Exosomes are lipid nanovesicles secreted from cells and found in all bodily fluids such as plasma, urine, and cerebrospinal fluid. Originally viewed as garbage disposal systems for cellular debris and proteins, they are now ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
